NEOGENOMICS LABORATORIES, INC.

Neogenomics Laboratories, Inc. specializes in advanced molecular and anatomic pathology testing services for federal healthcare systems, delivering high-complexity diagnostic solutions including fluorescence in situ hybridization (FISH), genomic sequencing, and hematologic malignancy analysis. The company provides specialized reference laboratory services critical for diagnosing and stratifying blood disorders, cancers, and rare diseases, with deep expertise in clinical genomics, cytogenetics, and laboratory information system integration. Their technical capabilities are focused on precision diagnostics for complex clinical cases, ensuring accurate, timely results to inform patient care pathways in high-stakes medical environments. Neogenomics distinguishes itself through its ability to handle highly specialized, low-volume, high-complexity testing that exceeds the capacity of standard clinical labs, serving as a trusted extension of federal medical facilities. The contractor maintains a consistent, long-standing relationship with the Department of Veterans Affairs, delivering off-site anatomic pathology, FISH testing, and specialized reference lab services to VA medical centers nationwide. They also support the Department of Health and Human Services with diagnostic reference testing for hematological and genomic applications, and provide limited but critical anatomic pathology services to the Department of Defense under formal performance work statements. These engagements reflect a pattern of sustained, mission-critical partnerships centered on diagnostic accuracy and operational reliability. Neogenomics operates primarily under NAICS 621511, focusing on medical laboratories that perform complex clinical testing requiring advanced instrumentation and certified personnel. Their market positioning is as a high-complexity reference lab provider for government healthcare systems, specializing in niche areas such as hematopathology and molecular diagnostics that require stringent quality controls and regulatory compliance. The company is structured as a private, for-profit entity headquartered in Fort Myers, Florida, with no active government certifications. Its geographic footprint is centered on serving federal medical networks through centralized laboratory operations, enabling nationwide support without physical on-site facilities at each client location.